Anti-EGFR antibody liposomes are novel drug delivery systems designed to target and treat cancers that overexpress the epidermal growth factor receptor (EGFR). These liposomes consist of a lipid bilayer encapsulating chemotherapeutic agents, which are conjugated with monoclonal antibodies directed against EGFR. This targeted approach enhances drug delivery to cancerous cells while minimizing side effects on healthy tissues.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-750 | Anti-EGFR/HER1 Recombinant Antibody (TAB-750) | Neut, ELISA, IF, IP, FuncS, FC, WB | IgG1 - kappa |
TAB-H35 | Anti-Human EGFR Recombinant Antibody (Futuximab) | IF, WB, Inhib | IgG1 - kappa |
TAB-0225CL | Human Anti-EGFR Recombinant Antibody (TAB-0225CL) | Block, Inhib, FuncS, Apop, In vivo | Chimeric (Mouse/Human) IgG1 |
PABX-051 | Recombinant Human Anti-EGFR Antibody (Matuzumab) | WB, Neut, FuncS, FC, ELISA, IF, Inhib | IgG |
TAB-464CQ | Anti-Human EGFR Recombinant Antibody (TAB-464CQ) | ELISA, IHC, FC, IP, IF, FuncS | IgG1, κ |
There are currently no Customer reviews or questions for VS-1024-FY140. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.